Vnitr Lek 2009, 55(2):97-104

Pathophysiology of metabolic acidosis in patients with reduced glomerular filtration rate according to Stewart-Fencl theory

J. Havlín1,*, K. Matoušovic1, O. Schück1, M. Horáčková1, J. Charvát1, K. Kotaška2, D. Králová1
1 Interní klinika 2. lékařské fakulty UK a FN Motol Praha, přednosta prof. MUDr. Milan Kvapil, CSc., MBA
2 Ústav klinické biochemie a patobiochemie 2. lékařské fakulty UK a FN Motol Praha, přednosta prof. MUDr. Richard Průša, CSc.

Aim:
Metabolic acidosis is a regular sign of renal insufficiency. Conventional assessment of acid-base balance using Henderson-Hasselbalch equation does not make identification of the cause of metabolic disorders possible as the serum HCO3- concentration might only reflect changes to the overall plasma ion spectrum. Therefore, we used the Stewart-Fencl approach that is based on a more detailed physical and chemical analysis and that showed that changes to serum HCO3- concentration are closely related to parameters not usually monitored in connection to acid-base balance.


Patient group and methodology:
We performed a single measurement of arterial or capillary blood pH and pCO2 in 69 non-dialysed patients with glomerular filtration rate ranging from 0.04 to 0.88 ml/s/1.73 m2 according to MDRD, standard calculation of serum HCO3- concentration using Henderson-Hasselbalch equation was carried out, and serum albumin and ion concentrations (Na+, K+, Cl, Pi) plus creatinine and urea concentrations were determined from venous blood.

Results:
Metabolic acidosis was present in 47 patients ([S-HCO3-] < 22 mmol/l) with the mean [S-HCO3-] value of 19.6 mmol/l for the entire group. We proved a statistically significant correlation between [S-HCO3-] and [SID] (p < 0.001), and between [S-HCO3-] and the individual [SID] determining factors: [Na+-Cl-], [UA-], [Pi-], [K+] (p < 0.01).

Conclusion:
Reduction in [S-HCO3-] in non-dialysed patients with reduced glomerular filtration is predominantly associated with a decrease in [Na+-Cl-] difference, the quantitative contribution of which to metabolic acidosis is more significant than the strong acids retention. In addition to [S-Cl-] increase, [S-Na+] reduction too has a major role in reducing the [Na+-Cl-] difference.

Keywords: renal insufficiency; metabolic acidosis; Stewart theory; strong ion difference; unidentified anions; [Na+-Cl-] difference

Received: April 29, 2008; Accepted: November 20, 2008; Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havlín J, Matoušovic K, Schück O, Horáčková M, Charvát J, Kotaška K, Králová D. Pathophysiology of metabolic acidosis in patients with reduced glomerular filtration rate according to Stewart-Fencl theory. Vnitr Lek. 2009;55(2):97-104.
Download citation

References

  1. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics and treatment. Am J Kidney Dis 2005; 45: 978-993. Go to original source... Go to PubMed...
  2. Wallia R, Greenberg A, Piraino B et al. Serum electrolyte patterns in end-stage renal disease. Am J Kidney Dis 1986; 8: 98-104. Go to original source... Go to PubMed...
  3. Hakim RM, Lazarus JM. Biochemical parameters in chronic renal failure. Am J Kidney Dis 1988; 11: 238-247. Go to original source... Go to PubMed...
  4. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61: 1444-1461. Go to original source... Go to PubMed...
  5. Fencl V, Leith DE. Stewart's quantitative acid-base chemistry: Applications in biology and medicine. Respir Physiol 1993; 91: 1-16. Go to original source... Go to PubMed...
  6. Jones NL. A quantitative physicochemical approach to acid-base physiology. Clin Biochem 1990; 23: 89-95. Go to original source... Go to PubMed...
  7. Corey HE. Stewart and beyond: New models of acid-base balance. Kidney Int 2003; 64: 777-787. Go to original source... Go to PubMed...
  8. Boyle M, Baldwin I. Introduction to an alternative view of acid-base balance: the strong ion difference or Stewart approach. Aust Crit Care 2002; 15: 14-20. Go to original source...
  9. Matoušovic K, Martínek V, Kvapil M. Acidobazická rovnováha tělesných tekutin a její kvantitaivní fyzikálně-chemické hodnocení. Aktuality v nefrologii 2002; 4: 150-156.
  10. Schück O, Matoušovic K. Vztah mezi pH a diferencí silných iontů (SID) ve vnitřním prostředí. Klin Biochem Metab 2005; 34: 32-35.
  11. Matoušovic K, Martínek V. Analýza a korekce poruch acidobazické rovnováhy na základě Stewartova-Fenclova principu. Vnitř Lék 2004; 7: 526-530.
  12. Rosival V. Explanation of the Stewart-Fencl views on the acid-base equilibrium. Vnitř Lék 2004; 11: 877.
  13. Schück O, Teplan V, Marečková O. MDRD formulas for GFR estimation. Is there any difference among them in prediction of renal inulin clearance? Clin Nephrol 2005; 64: 326-327. Go to original source... Go to PubMed...
  14. Figge J, Jabor A, Kazda A et al. Anion gap and hypoalbuminemia. Crit Care Med 1998; 26: 1807-1810. Go to original source... Go to PubMed...
  15. Wilkes P. Hypoproteinemia, strong ion difference, and acid-base status in critically ill patients. J Appl Physiol 1998; 5: 1740-1748. Go to original source... Go to PubMed...
  16. Figge J, Mydosh T, Fencl V. Serum proteins and acid-base equilibria a follow up. J Lab Clin Med 1992; 120: 713-719.
  17. Figge J, Rossing TH, Fencl V. The role of serum proteins in acid-base equilibria. J Lab Clin Med 1991; 117: 453-467.
  18. Corey HE. The anion gap (AG): studies in the nephrotic syndrome and diabetic ketoacidosis (DKA). J Lab Clin Med 2006; 147: 121-125. Go to original source... Go to PubMed...
  19. McAuliffe JJ, Lind LJ, Leith DE et al. Hypoproteinemic alkalosis. Am J Med 1986; 81: 86-90. Go to original source... Go to PubMed...
  20. Story DA, Tosolini A, Bellmo R et al. Plasma acid-base changes in chronic renal failure: A Stewart analysis. Int J Art Org 2005; 28: 961-965. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.